Tissue Specimen Collection for Study of Inherited Diseases Involving Non-muscle Gene Mutations

This study is currently recruiting participants.
Verified February 2013 by National Institutes of Health Clinical Center (CC)
Sponsor:
Information provided by:
National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier:
NCT00083499
First received: May 25, 2004
Last updated: March 27, 2013
Last verified: February 2013
  Purpose

This study will collect blood, urine, and other tissue samples from patients with Pentalogy of Cantrell and other inherited diseases that involve mutations in non-muscle myosin genes. Pentalogy of Cantrell is a very rare disorder in which patients have a combination of severe defects of the middle of the chest including the sternum (breastbone), diaphragm, heart, and abdominal wall. The defect is apparent before birth or at birth. If the mutant gene is identified in the patient tissue samples will also be collected from relatives of the patients.

Participants undergo a medical evaluation that may include a medical history routine blood tests, urine collection, chest x-ray, and electrocardiogram. In addition, blood and urine samples are collected for protein and gene studies. The blood is drawn through a very small needle placed in an arm vein. Children may choose to have a buccal (cheek) sample taken instead of blood draw. Buccal samples can be collected by a cheek swab, in which a soft brush is rubbed on the inside lining of the mouth, or by having the child hold a tablespoon of mouthwash in his or her mouth for a full minute and then spit the mouthwash into a container.

Other tissue samples may be collected from patients at the time of any surgical procedure that may be required as part of their general medical care.

Some of the cells obtained from patients or their relatives may be used to establish cell lines (a living tissue sample) that can be grown in the laboratory and used for experiments.


Condition
Inborn Genetic Diseases
Pentalogy of Cantrell

Study Type: Observational
Official Title: Human Diseases With Mutation of Non-Muscle Myosin Heavy and Light Chain Genes

Further study details as provided by National Institutes of Health Clinical Center (CC):

Estimated Enrollment: 50
Study Start Date: May 2004
Detailed Description:

The purpose of this protocol is to collect protein, DNA, and RNA from blood and/or tissue samples as well as urine samples of patients with Pentalogy of Cantrell or other diseases that could involve mutation of any of the genes encoding nonmuscle myosin heavy chains (NMHC IIA on chromosome 22, IIB on chromosome 17 or IIC on chromosome 19). Mutations of nonmuscle myosin IIA have been shown to result in human defects involving blood platelets, kidney, hearing and sight (Epstein's Syndrome, May-Hegglin/Fechtner Syndrome). We have recently generated a mouse model of the mutations found in humans in NMHC IIA which duplicates many of the abnormalities that are present in humans. Defects in patients with mutations in nonmuscle myosin IIB are not known yet. However, we have produced a mouse model with the mutant mice exhibiting problems with ventral wall closure, and extrathoracic location of the heart (ectopia cordis), guts and liver. The mice had severe defects in both the heart and brain, and resemble humans born with the rare syndrome Pentalogy of Cantrell, who manifest these same abnormalities. Humans with a point mutation in nonmuscle myosin IIC have been reported and suffer from loss of hearing.

  Eligibility

Ages Eligible for Study:   2 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria
  • INCLUSION CRITERIA:

    i. Index Cases

    1. Those patients who have Pentalogy of Cantrell (as defined under STUDY DESIGN) or other diseases that could involve mutation of any of the nonmuscle myosin genes that will be defined in future amendments.
    2. Outside Institutions- All ages will be included

At the Clinical Center-Those subjects that are greater than or equal to 2 years of age and older.

ii. Relatives of Index Cases

  1. We may obtain samples from family members and/or relatives of those individuals who have mutations for genotyping and/or the analysis of proteins or DNA/RNA in the future. Only family members who have a mutation in myosin IIB, IIA, IIC, or interacting proteins will be further examined.
  2. Outside Institutions - All ages will be included.

    At the Clinical Center - Those subjects that are greater than or equal to 2 years of age and older.

  3. Patients and family who have the genotype of interest will undergo examination as listed above under Baseline Evaluation for Screening (page 6).

iii. Fetal tissue:

  1. Echocardiographic written report documenting evidence of ectopia cordis or a defect in ventricular wall closure.
  2. Research use of the fetal tissue under the following conditions only:

    1. No profits will be involved;
    2. NIH researchers will have no involvement in the termination of pregnancy, and
    3. The tissue must be obtained in accordance with state and local law.

EXCLUSION CRITERIA:

In screening for subjects who may be asymptomatic, but who could be carrying the gene, we will exclude all children under the age of 2.

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00083499

Contacts
Contact: Robert S Adelstein, M.D. (301) 496-1865 adelster@nhlbi.nih.gov

Locations
United States, California
University of California, San Francisco Recruiting
San Francisco, California, United States, 94143-0720
United States, Maryland
National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting
Bethesda, Maryland, United States, 20892
Contact: For more information at the NIH Clinical Center contact Patient Recruitment and Public Liaison Office (PRPL)     800-411-1222 ext TTY8664111010     prpl@mail.cc.nih.gov    
United States, Massachusetts
Brigham and Women's Hospital Recruiting
Boston, Massachusetts, United States, 02115
United States, Ohio
Cincinnati Children's Hospital Medical Center Recruiting
Cincinnati, Ohio, United States, 45229-3039
United States, Texas
University of Texas Southwestern Medical Center Recruiting
Dallas, Texas, United States, 75390
Israel
Ben Gurion University Recruiting
Beersheva, Israel, 84105
Sponsors and Collaborators
Investigators
Principal Investigator: Robert S Adelstein, M.D. National Heart, Lung, and Blood Institute (NHLBI)
  More Information

Additional Information:
Publications:
ClinicalTrials.gov Identifier: NCT00083499     History of Changes
Other Study ID Numbers: 040202, 04-H-0202
Study First Received: May 25, 2004
Last Updated: March 27, 2013
Health Authority: United States: Federal Government

Keywords provided by National Institutes of Health Clinical Center (CC):
Pental of Cantrell
TAS Syndrome
Midline Defects
Contractile Proteins
Herniation
Nonmuscle Myosin IIC
Pentalogy of Cantrell
Non-muscle Myosin Heavy Chain Genes

Additional relevant MeSH terms:
Genetic Diseases, Inborn
Pentalogy of Cantrell
Neural Tube Defects
Nervous System Malformations
Nervous System Diseases
Abnormalities, Multiple
Congenital Abnormalities

ClinicalTrials.gov processed this record on May 23, 2013